向自:聚达丁在诱导AML细胞死亡中的作用
Ping Fu1, Qing Luo1, Chao Wang2
1Department of GCP, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Frontiers in pharmacology
|December 4, 2024
概括
聚达丁 (PD) 通过抑制癌细胞生长和诱导亡来治疗急性髓性白血病 (AML) 是有前途的. 这种天然化合物有效调节自,为早期AML治疗干预提供了潜力.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性髓性白血病 (AML) 是一种流行成人血液癌症,起源于白血病干细胞 (LSCs).
- 聚达丁 (PD) 具有潜在的抗癌性质,包括增强瘤亡和自调节.
研究的目的:
- 评估聚达丁 (PD) 在急性髓性白血病 (AML) 的治疗潜力.
- 为了研究PD的作用机制,涉及AML细胞的自调节.
主要方法:
- 使用KASUMI-1 AML细胞系和小鼠移植瘤模型的ex vivo和in vivo研究.
- 分子对接以预测PD与自相关蛋白5 (ATG5) 的相互作用.
- 评估细胞增殖,细胞亡和自性通路调节.
主要成果:
- 通过调节自,PD抑制了KASUMI-1细胞增殖并诱导了细胞亡.
- 分子对接表示PD抑制ATG5无化并增强其稳定性,激活自.
- 在体内研究证实了AML小鼠模型中PD的有效性和安全性.
结论:
- 聚达丁在急性髓性白血病 (AML) 中显示出显著的治疗潜力.
- PD的机制涉及调节ATG5-介导的自途径.
- PD是AML早期干预的有希望的候选人,具有潜在的临床应用.
更多相关视频
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Phagocytosis of Apoptotic Cells
3.7K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


